SCHEMBL5597658

SCHEMBL5597658

OC[C@H](F)Cc1ccccc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPA1 O75762 1/20 0.54
CYP1A2 P05177 1/20 0.46
EPHX1 P07099 2/20 0.46
TSHR P16473 1/20 0.46
ALPI P09923 1/20 0.43
PKM P14618 1/20 0.43
PTGS1 P23219 1/20 0.43
XIAP P98170 1/20 0.43
SLC7A5 Q01650 1/20 0.43
OPRM1 P35372 1/20 0.43
KCNH2 Q12809 1/20 0.43
SLC6A2 P23975 2/20 0.43
TAAR1 Q96RJ0 2/20 0.43
MAOA P21397 1/20 0.43
SLC6A4 P31645 1/20 0.43
SLC6A3 Q01959 1/20 0.43
SIGMAR1 Q99720 1/20 0.43
CYP2A6 P11509 1/20 0.43
ADORA2A P29274 1/20 0.43
ADORA1 P30542 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5597661 1.00 TRPA1 (0.54) TRPA1CYP1A2EPHX1TSHRALPI
SCHEMBL30657566 0.85 EPHX1 (0.55) TRPA1CYP1A2EPHX1ALPIPKM
SCHEMBL5001745 0.81 EPHX1 (0.52) CYP1A2EPHX1ALPIPKMPTGS1
SCHEMBL4679591 0.81 EPHX1 (0.52) CYP1A2EPHX1ALPIPKMPTGS1
SCHEMBL26497007 0.78 EPHX1 (0.48) TRPA1CYP1A2EPHX1ALPIPKM
SCHEMBL1665737 0.78 EPHX1 (0.48) CYP1A2EPHX1OPRM1KCNH2SLC6A2
SCHEMBL6880807 0.77 TDP1 (0.50) TRPA1TSHRTDP1GRIN2BANPEP
SCHEMBL6880811 0.77 TDP1 (0.50) TRPA1TSHRTDP1GRIN2BANPEP
SCHEMBL28749751 0.76 EPHX1 (0.46) TRPA1CYP1A2EPHX1ALPIPKM
SCHEMBL21677972 0.76 TRPA1 (0.50) TRPA1EPHX1OPRM1KCNH2SLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7265249-B2 Enantioselective alpha-fluorination of aldehydes using chiral organic catalysts CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2007-09-04 US disclosed
US-20060189830-A1 Enantioselective alpha-fluorination of aldehydes using chiral organic catalysts CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2006-08-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060189830-A1 Enantioselective alpha-fluorination of aldehydes using chiral organic catalysts ALDH3A1, ALDH1A1, POLL TRPA1 2121/4885CYP1A2 1377/4885EPHX1 436/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.